KAZIA THERAPEUTICS-SPON ADR (KZIA) Stock Analyst Ratings
NASDAQ:KZIA - Nasdaq - US48669G3039 - ADR - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to KZIA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 14.28. This target is 40.7% above the current price.
KZIA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about KZIA.
In the previous month the buy percentage consensus was at a similar level.
KZIA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-11 | Maxim Group | Maintains | Buy -> Buy |
| 2025-02-06 | Maxim Group | Initiate | Buy |
| 2024-07-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-11 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2022-08-02 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-08-02 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-10-14 | Maxim Group | Initiate | Buy |